Susan Bibeault

Dana Faber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2010

Phase II Study of TKI258 in Advanced Urothelial Carcinoma
March 2010 - March 2012
Carcinoma
Carcinoma, Transitional Cell
Tki258



